Subject category:
Strategy and General Management
Published by:
International Institute for Management Development (IMD)
Version: 06.02.2003
Length: 5 pages
Data source: Published sources
Share a link:
https://casecent.re/p/11586
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
This is the second of a two-case series (IMD-3-1105 and IMD-3-1106). In December 1999, one year after the merger of Hoechst and Rhone-Poulenc, the new company Aventis had increased its revenues, operating margins and reduced costs. It was also well positioned to achieve some of its major strategic goals. In November 2000, Aventis announced its decision to sell off its crop sciences operations. In this way, Aventis became a focussed pharmaceuticals company.
Location:
Industry:
Size:
EUR14 billion, 90,000 employees
Other setting(s):
December 1999
Subject category:
Strategy and General Management
Published by:
International Institute for Management Development (IMD)
Version: 23.07.2004
Length: 21 pages
Data source: Published sources
About
Abstract
This is the second of a two-case series (IMD-3-1105 and IMD-3-1106). In December 1999, one year after the merger of Hoechst and Rhone-Poulenc, the new company Aventis had increased its revenues, operating margins and reduced costs. It was also well positioned to achieve some of its major strategic goals. In November 2000, Aventis announced its decision to sell off its crop sciences operations. In this way, Aventis became a focussed pharmaceuticals company.
Settings
Location:
Industry:
Size:
EUR14 billion, 90,000 employees
Other setting(s):
December 1999
Related
Subject category:
Strategy and General Management
Published by:
International Institute for Management Development (IMD)
Version: 23.07.2004
Length: 21 pages
Data source: Published sources